Endiatx
Endiatx is a privately held medical device company developing PillBot, an investigational swallowable capsule robot with self-propulsion and remote-controlled navigation, targeting the 75+ million patients annually who undergo invasive stomach endoscopy procedures.
- Company typePrivate
- Founded2019
- HeadquartersHayward, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Endiatx does
Endiatx is a privately held medical device company founded in 2019 and headquartered in Hayward, California, that is developing swallowable capsule technologies for gastrointestinal tract visualization. The company's investigational platform comprises three core products: PillBot, a self-propelled, remote-controlled capsule robot with multiple pump jet motors designed for maneuverability within the stomach; PillVue, a capsule imaging platform for real-time visualization; and Cortex, an external clinician workstation that interfaces with the capsule technologies. The technical platform emphasizes 480/640p live video at 15fps with a 170° field of view, wireless data transmission via a high-bandwidth transceiver, and lithium-ion battery operation, with future iterations of PillBot potentially incorporating AI-assisted navigation for autonomous positioning. All three products are explicitly investigational and not FDA cleared or approved, and the company itself states the device is not available for commercial use.
Endiatx targets the estimated 75+ million patients annually who undergo invasive stomach endoscopy procedures globally, with the thesis that up to 80% of these procedures are diagnostic-only and could be replaced by a less invasive, anesthesia-free capsule alternative. The company's stated value proposition centers on reducing procedure costs (traditional endoscopy can cost up to $2,000), eliminating anesthesia requirements, reducing staffing from 3-4 medical professionals to one, eliminating pre-operative visits, and shortening wait times from up to 3 months to approximately 10 minutes of real-time video from inside the stomach.
The company is pre-revenue. Its current go-to-market motion is centered on an Investigator-Initiated Studies program that makes investigational technologies available to qualified investigators and research institutions for independent clinical research, in exchange for potential product access, technical information, training, or limited research funding. Endiatx has raised approximately $21 million in total funding through a January 2025 $12 million Series A round with investments from SINC Fund (the venture capital arm of the Society of American Gastrointestinal and Endoscopic Surgeons) and Varia Ventures Management Co. The company is also a member of MedTech Innovator, received an investment from Ruttenberg Gordon Investments, and was selected for the MedTech World Startup Pitch Competition in Dubai in February 2026.
Endiatx firmographics
Firmographics- Name
- Endiatx
- Legal name
- Endiatx, Inc.
- Website
- https://endiatx.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Endiatx is a privately held medical device company developing PillBot, an investigational swallowable capsule robot with self-propulsion and remote-controlled navigation, targeting the 75+ million patients annually who undergo invasive stomach endoscopy procedures.
- Ownership category
- akta.pro rank
Endiatx industry classification
Industry- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)
- akta.pro secondary industry
- Advanced Endoscopy (ERCP/EUS/Interventional) (HLAKAEAC)
Keywords
Where Endiatx is headquartered
LocationHeadquarters
- HQ city
- Hayward
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Endiatx business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- PillBot Medical Device Sales: Sale of disposable capsule endoscopy devices to healthcare providers and clinical settings. PillBot is designed to be low-cost and disposable, suggesting a consumable/hardware revenue model where healthcare facilities purchase devices for patient procedures.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Endiatx product offering
Product offeringCore offering
Endiatx is developing an investigational platform of swallowable capsule technologies for gastrointestinal endoscopy, centered on the PillBot self-propelled, remote-controlled capsule robot and PillVue capsule imaging device, paired with the Cortex external clinician console. The platform is designed to enable real-time visualization of the stomach without anesthesia or pre-operative visits, positioning as a low-cost disposable alternative to traditional $2,000 endoscopy procedures. All products are investigational and not yet FDA cleared or commercially available.
Product overview
Endiatx is developing a platform of investigational swallowable capsule technologies designed for real-time visualization from within the stomach and GI tract. The platform includes three core products: PillBot (a self-propelled, remote-controlled capsule robot with AI-assisted navigation capabilities under development), PillVue (a capsule imaging platform for real-time stomach visualization), and Cortex (the external clinician console that interfaces with both capsule devices to receive live video streams and enable real-time interaction).
Differentiator
Problem solved
Functional benefit
Brands
- PillBot: Investigational swallowable capsule robotic platform under development for real-time visualization of the stomach with active locomotion and AI-assisted navigation capabilities.
- PillVue
- Cortex
Quantifiable outcome
- Up to 80% of traditional endoscopy procedures are diagnostic only and could potentially be replaced by PillBot's less invasive approach
- +3 more outcomes
Companies that use Endiatx
Customer profileSegments2 records
Ideal customer profiles2 records
Endiatx technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature7 records
Endiatx partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights4 records
Endiatx competitors and assessment
Company assessmentMarket position
Weaknesses5 records
Competitive moat4 records
Customer concentration
Endiatx social profiles
Digital presenceEndiatx financial estimates
Financial estimateRevenue estimate
Valuation estimate
Endiatx leadership team
Management profileNumber of profiles
Endiatx funding detail
Funding detailFunding overview
Funding rounds5 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Endiatx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Endiatx
What does Endiatx do?
Endiatx is developing an investigational platform of swallowable capsule technologies for gastrointestinal endoscopy, centered on the PillBot self-propelled, remote-controlled capsule robot and PillVue capsule imaging device, paired with the Cortex external clinician console. The platform is designed to enable real-time visualization of the stomach without anesthesia or pre-operative visits, positioning as a low-cost disposable alternative to traditional $2,000 endoscopy procedures. All products are investigational and not yet FDA cleared or commercially available.
Is Endiatx a public or private company?
Endiatx is a private company. It is currently operating.
When was Endiatx founded?
Endiatx was founded in 2019. It employs 11 to 50 people.
Where is Endiatx based?
Endiatx is headquartered in Hayward, United States, in the North America region.
How does Endiatx make money?
One revenue line is on record: pillBot Medical Device Sales.
Does Endiatx have an API?
No public API is recorded for Endiatx.
What industry is Endiatx in?
Its primary akta.pro industry code is HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation), with a secondary code of HLAKAEAC, Advanced Endoscopy (ERCP/EUS/Interventional). Its NAICS code is 334510 and its SIC code is 3841.